Skip to main content
Daily Report

Daily Cosmetic Research Analysis

09/04/2025
3 papers selected
3 analyzed

Across cosmetic and aesthetic medicine, evidence consolidates around energy-based skin rejuvenation (Er:YAG and radiofrequency outperforming other modalities), and a prospective study suggests hyaluronic acid rhinofiller may also improve nasal airflow alongside aesthetics. A Europe-wide exposure model for UV filters (e.g., oxybenzone, octinoxate) aligns predictions with monitoring, enabling more robust aquatic safety assessments and informing cosmetic ingredient stewardship.

Summary

Across cosmetic and aesthetic medicine, evidence consolidates around energy-based skin rejuvenation (Er:YAG and radiofrequency outperforming other modalities), and a prospective study suggests hyaluronic acid rhinofiller may also improve nasal airflow alongside aesthetics. A Europe-wide exposure model for UV filters (e.g., oxybenzone, octinoxate) aligns predictions with monitoring, enabling more robust aquatic safety assessments and informing cosmetic ingredient stewardship.

Research Themes

  • Energy-based skin rejuvenation and resurfacing
  • Functional outcomes of aesthetic injectables
  • Environmental safety assessment of cosmetic UV filters

Selected Articles

1. A systematic review and meta-analysis of the comparison between lasers and other therapeutic modalities in skin rejuvenation and resurfacing with a focus on RCTs.

67Level IIMeta-analysis
Lasers in medical science · 2025PMID: 40906045

Across six comparative studies (n=497), Er:YAG laser showed the highest proportion of excellent responses, while radiofrequency achieved the highest proportion of good responses; IPL tended to yield fair improvements. Findings suggest Er:YAG, alone or combined with radiofrequency, may provide superior rejuvenation outcomes versus other modalities.

Impact: Synthesizing randomized split-face and comparative trials, this analysis informs device selection and supports Er:YAG ± radiofrequency for skin rejuvenation. It provides comparative performance signals where direct head-to-head evidence is sparse.

Clinical Implications: For facial rejuvenation, clinicians may prioritize Er:YAG for deeper resurfacing goals and consider combining with radiofrequency to enhance outcomes, while counseling that IPL typically yields more modest improvements. Standardizing outcome measures will facilitate individualized modality selection.

Key Findings

  • Six studies (n=497) yielded pooled effectiveness proportions: excellent 18%, good 31%, fair 40%, poor 26%, no change 14%.
  • Er:YAG laser had the highest proportion of excellent responses (20%).
  • Radiofrequency showed the highest proportion of good responses (39%), while IPL more often produced fair responses (39%).
  • Split-face and side-by-side randomized designs strengthened within-subject comparisons.

Methodological Strengths

  • Inclusion of randomized split-face and side-by-side randomized trials reducing inter-individual variability
  • Direct modality-to-modality comparisons across multiple energy-based devices

Limitations

  • Small number of trials and heterogeneity in outcome categorization and protocols
  • Potential publication bias and limited long-term safety data

Future Directions: Conduct head-to-head RCTs with standardized, validated outcome scales and longer follow-up; evaluate combined Er:YAG+RF protocols and safety across diverse skin types.

AIMS AND OBJECTIVES: This systematic review and meta-analysis sought to compare the efficacy of lasers with other modalities in skin rejuvenation and resurfacing. Methodology: The database was thoroughly searched, and six articles meeting specific inclusion criteria were selected for meta-analysis. Inclusion criteria comprised studies that compared lasers with other methods, with four studies focusing on laser comparisons and two studies comparing more than two methods. The selected articles encompassed two randomized split-face trials, one side-by-side randomized clinical trial, and three comparative studies. The effectiveness of treatments was categorized as excellent, good, fair, poor, no change, or worsening. Article review and data extraction were conducted using Endnote X8, followed by analysis and categorization of the studies. RESULTS: The meta-analysis, involving six studies with 497 patients (mean age: 49.65 years), revealed an overall pooled prevalence of treatment effectiveness: 18% for "excellent," 31% for "good," 40% for "fair," 26% for "poor," and 14% for "no change." Erbium YAG laser exhibited superior results in the "excellent" category, with 20% displaying excellent responsiveness, and in the "good" category, 39% of radiofrequency cases treated with Erbium YAG laser demonstrated favorable results. Conversely, intense pulsed light showed better responsiveness in the "fair" group, with 39% of cases demonstrating fair results. CONCLUSION: Our study indicated a higher percentage of excellent responses compared to other skin rejuvenation treatments with Erbium YAG laser and the highest percentage of good responses with radiofrequency treatment. However, intense pulsed light treatment yielded superior results in the fair response group. Based on our findings, it is evident that utilizing Erbium YAG laser in conjunction with radiofrequency represents a secure approach that surpasses other methods in enhancing and restoring skin quality. Furthermore, a plausible suggestion is made that a combination of these two methods may introduce the most optimal approach for skin rejuvenation in the future.

2. Spatially referenced environmental exposure model for down-the-drain substance emissions across european Rivers for aquatic safety assessments.

65.5Level VCohort
Integrated environmental assessment and management · 2025PMID: 40905630

A Europe-wide, spatially resolved model predicts concentrations of down-the-drain chemicals, including cosmetic UV filters (oxybenzone, octinoxate), by incorporating WWTP performance, river routing, and in-stream decay. Predictions aligned with monitoring within a factor of 2–8, supporting prospective aquatic safety assessments against PNECs and tiered risk approaches.

Impact: Provides a validated, spatially explicit exposure tool encompassing UV filters used in personal care, enabling regulators and industry to anticipate environmental concentrations without monitoring every catchment.

Clinical Implications: While not altering bedside care, these data inform sunscreen ingredient stewardship and public health messaging (e.g., reef-safe choices), balancing individual photoprotection with environmental risk. Dermatologists can counsel patients and policymakers using risk assessments grounded in modeled and monitored data.

Key Findings

  • Developed an EU-wide, spatially referenced exposure model leveraging WWTP data, river connectivity/routing, and in-stream decay.
  • Case studies included two surfactants and two cosmetic UV filters (oxybenzone, octinoxate).
  • Modeled 90th percentile concentrations agreed with monitoring within a factor of 2–8, indicating predictive yet conservative performance.
  • Model supports prospective safety assessments by comparison to PNECs and aligns with tiered risk frameworks.

Methodological Strengths

  • Integrates high-resolution WWTP inventories, hydrological routing, and chemical-specific removal/decay
  • External validation against geographically distributed monitoring datasets

Limitations

  • Relies on assumed emissions and parameter uncertainties; site-specific usage patterns may vary
  • Monitoring data are unevenly distributed; mixture effects and transformation products not fully addressed

Future Directions: Incorporate temporal dynamics (seasonality, extreme flows), refine emissions using market- and behavior-based data, and expand validation for additional cosmetic actives and transformation products.

A spatially referenced environmental exposure model for down-the-drain substance emissions was developed for Europe including the 27 European Union member states, Norway, Switzerland, and the United Kingdom. The model builds upon the global modeling framework that leverages the well-established iSTREEM model for the United States and further expands global coverage of the framework. The data is parameterized using European Union data on waste water treatment plants, locations, infrastructure, and global spatial datasets on population and river flow rates and routing. The model provides substance concentration distributions based on spatial variability of these parameters across Europe while taking into account river connectivity, chemical routing between rivers, and in-stream decay. Chemical-specific model inputs include wastewater treatment removals, in-stream decay rates, and emissions. The model is demonstrated for four case study chemicals that are used in consumer products with down-the-drain disposal routes: linear alkylbenzene sulfonate and alkyl sulfate are common surfactants used in laundry detergents, and oxybenzone and octinoxate are UV-filters used in personal care products. Monitoring data were collected to represent spatial variability across Europe as a comparison to modeled values. Modeled concentrations were found to be predictive while still being conservative, with 90th percentile modeled concentrations agreeing with monitored concentrations within a factor of 2-8 across the case study substances. We further demonstrate how the model can be applied in prospective safety assessments by comparing modeled concentrations to previously established predicted no-effect concentrations, and also demonstrate how the model is consistent with tiered risk assessment approaches when compared to the monitoring data assessments.

3. Nasal Airflow Improvement After Rhinofiller: Evaluation Using PROMs and Rhinomanometry.

64.5Level IIICohort
Aesthetic plastic surgery · 2025PMID: 40906286

In 121 patients receiving VYC-25 rhinofiller, NOSE scores improved by 33.7 points and FACE-Q nasal satisfaction increased by 21% over 6 months, while rhinomanometry showed a 24% reduction in inspiratory pressure gradient at 100 Pa. Findings suggest potential functional airflow benefit alongside aesthetic gains in carefully selected patients (Level III).

Impact: Introduces objective airflow data (rhinomanometry) to an aesthetic injectable procedure, bridging function and form and informing patient selection and counseling.

Clinical Implications: In mild deviation with dynamic nasal valve compromise, hyaluronic acid rhinofiller may yield functional airflow improvements but should not be considered a substitute for septorhinoplasty. Incorporating PROMs and rhinomanometry into assessment can guide candidacy and track benefit.

Key Findings

  • Prospective evaluation of 121 patients receiving VYC-25 rhinofiller with PROMs at baseline, 1, 3, and 6 months.
  • NOSE scores decreased by 33.7 ± 9.4 points (p<0.05); FACE-Q nasal satisfaction improved by 21% (±5%).
  • Rhinomanometry showed a 24% (±4%) reduction in inspiratory pressure gradient at 100 Pa at 6 months (p<0.05).
  • Level of Evidence III; not a substitute for surgical correction.

Methodological Strengths

  • Combined validated PROMs (FACE-Q, NOSE) with objective rhinomanometry
  • Prospective design with 6-month follow-up and >100 participants

Limitations

  • Nonrandomized, single-arm design without a control group
  • Device-/product-specific (VYC-25) and limited to selected mild-deviation cases

Future Directions: Randomized controlled or matched comparative studies versus surgical and non-surgical alternatives; longer-term safety and functional durability; imaging-correlated airflow metrics.

INTRODUCTION: Nonsurgical rhinofiller is increasingly used for aesthetic nasal reshaping, but little is known about its functional impact on nasal airflow. This study evaluates nasal airflow changes after rhinofiller using patient-reported outcome measures and objective rhinomanometry. METHODS: One hundred and twenty-one patients with mild nasal deviation, positive Cottle test, and no prior nasal surgery underwent rhinofiller with VYC-25. Patients completed FACE-Q and NOSE scale questionnaires preoperatively and at 1, 3, and 6 months post-treatment. Objective active anterior rhinomanometry was performed preoperatively and at 6 months. RESULTS: NOSE scale showed significant improvement from baseline to 6 months (mean reduction of 33.7 ± 9.4 points; p<0.05). FACE-Q nasal satisfaction module showed improvement by 21% (± 5%). Rhinomanometry demonstrated a 24% (± 4%) reduction in inspiratory pressure gradient at 100 Pa (p <0.05). CONCLUSIONS: Rhinofiller may provide both aesthetic enhancement and functional improvement in nasal airflow in selected patients. Patients should be informed that this is not a substitute for surgical septorhinoplasty. LEVEL OF EVIDENCE III: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .